BELITE BIO
Belite Bio focused on first-in-class therapeutics targeting untreatable inherited orphan diseases and age-related metabolic diseases, including atrophic age-related macular degeneration, stargardt disease, and nonalcoholic steatohepatitis. They develop anti-RBP4 therapies to treat age-related metabolic diseases, including macular degeneration, liver disease, and diabetes. Their technology platform effectively reduces circulating levels of RBP4, a vitamin A transporter protein linked to the development of aging metabolic diseases, including dry age-related macular degeneration, liver disease, and diabetes.
BELITE BIO
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.belitebio.com
Total Employee:
11+
Status:
Active
Total Funding:
55 M USD
Technology used in webpage:
IPv6 Fastly Hosted Akamai Hosted
Similar Organizations
Cambium Oncology
Cambium Oncology is a pre-clinical start-up focused on developing company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Medgene Labs
Medgene Labs is a vaccine prescriber for veterinarians.
MetrioPharm
MetrioPharm is a clinical stage pharmaceutical development company.
Novateinbio
Novatein Biosciences is a biological reagents company.
Ohm Oncology
Ohm Oncology is a drug development company
RH Nanopharmaceuticals
RH Nanopharmaceuticals is a pharmaceutical research and development company.
Scaffold Therapeutics
A venture backed, tech-accelerated drug development company.
Vivozon
Vivozon is a pharmaceutical drug development company.
XEME Biopharma
XEME Biopharma is a clinical-stage pharmaceutical development business.
Stock Details
Official Site Inspections
http://www.belitebio.com Semrush global rank: 8.48 M Semrush visits lastest month: 527
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Belite Bio"
Belite Bio - LinkedIn
Belite Bio | 1,389 followers on LinkedIn. Belite Bio (NASDAQ: BLTE) is a San Diego based clinical stage drug development company targeting untreatable …See details»
Belite Bio - Crunchbase Company Profile & Funding
Belite Bio focused on first-in-class therapeutics targeting untreatable inherited orphan diseases and age-related metabolic diseases, including atrophic age …See details»
Belite Bio (BLTE) Company Profile & Description - Stock Analysis
6 days ago Company profile for Belite Bio, Inc (BLTE) stock, with a description, list of executives, contact details and other key facts.See details»
Investor Relations | Belite Bio, Inc.
Jun 19, 2025 The Investor Relations website contains information about Belite Bio, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Belite Bio - Craft
Oct 29, 2024 Belite Bio has 1 employees at their 1 location. See insights on Belite Bio including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Belite Bio Information - RocketReach
Belite Bio is a Biotechnology Research, Drug Discovery, and Pharmaceuticals company located in San Diego, California with 19 employees. Find top employees, contact details and business …See details»
Belite Bio Company Profile | Management and Employees List
Find contact information for Belite Bio. Learn about their Research & Development, Business Services market share, competitors, and Belite Bio's email format.See details»
Belite Bio Inc - Cruelty Free Investing
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular …See details»
Home | Belite Bio
Our pipeline of novel therapies is built on our extensive Retinol Binding Protein 4 (RBP4) intellectual property portfolio and is focused on meeting the unmet …See details»
Belite Bio - VentureRadar
"Belite Bio™ is a San Diego-based clinical stage biopharmaceutical drug development company targeting untreatable age-related metabolic diseases, including macular degeneration, liver …See details»
Our Team | Belite Bio
Dr. Tom Lin (Yu-Hsin Lin) is the Founder, Chairman, and Chief Executive Officer of Belite Bio. Dr. Lin is also the Founder of Lin BioScience, Inc. (TPEx: 6696), our ultimate controlling …See details»
Belite Bio Announces $25 Million Registered Direct Offering
For more information, follow us on Twitter, Instagram, LinkedIn, Facebook or visit us at www.belitebio.com. Important Cautions Regarding Forward Looking StatementsSee details»
Investor FAQs | Belite Bio, Inc.
The Investor Relations website contains information about Belite Bio, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
News Releases - Belite Bio, Inc.
The Investor Relations website contains information about Belite Bio, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
BeliteBio | Belite Bio
Belite Bio™ is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases with significant …See details»
Belite Bio Announces Availability of Annual Report on Form 20-F …
SAN DIEGO, March 17, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinical stage biopharmaceutical drug development company, today announced …See details»
About | Belite Bio
We are a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics that address significant unmet medical needs in ophthalmology, liver …See details»
News Release Details - investors.belitebio.com
For more information, follow us on Twitter, Instagram, LinkedIn, Facebook or visit us at www.belitebio.com. Important Cautions Regarding Forward Looking Statements This press …See details»
News Release Details - investors.belitebio.com
SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc ("BLTE" or the "Company") (Nasdaq: BLTE), a clinical-stage biopharmaceutical drug development company focused on …See details»
Clinical Trials | Belite Bio
The PHOENIX trial is Phase 3, multicenter, double-masked, placebo-controlled, randomized, fixed-dose clinical study designed to evaluate the efficacy and safety of Tinlarebant in patients …See details»